{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:54:08Z","timestamp":1786769648482,"version":"build-2736575974"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL126901"],"award-info":[{"award-number":["R01HL126901"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2018.00097","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T15:00:38Z","timestamp":1533308438000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease"],"prefix":"10.3389","volume":"5","author":[{"given":"Julius L.","family":"Decano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","article-title":"Monocyte-Macrophages and T Cells in Atherosclerosis","volume":"47","author":"Tabas","year":"","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nature Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MOL.0b013e328363d298","article-title":"Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms","volume":"24","author":"Koltsova","year":"2013","journal-title":"Curr Opin lipidol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N E J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of the centers for disease control\/american heart association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"Sabatine","year":"2007","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","article-title":"A test in context: high-sensitivity C-reactive protein","volume":"67","author":"Ridker","year":"2016","journal-title":"J Am. College Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/08916934.2015.1027815","article-title":"Macrophages in vascular inflammation\u2013From atherosclerosis to vasculitis","volume":"48","author":"Shirai","year":"2015","journal-title":"Autoimmunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/ATVBAHA.116.306926","article-title":"Delta-Like Ligand 4-Notch Signaling in Macrophage Activation","volume":"36","author":"Nakano","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"35234","DOI":"10.1038\/srep35234","article-title":"Bone marrow-derived and peritoneal macrophages have different inflammatory response to oxLDL and M1\/M2 marker expression - implications for atherosclerosis research","volume":"6","author":"Bisgaard","year":"2016","journal-title":"Sci Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/S0735-1097(02)02834-6","article-title":"Mechanisms of plaque vulnerability and rupture","volume":"41","author":"Shah","year":"2003","journal-title":"J Am College Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/01.CIR.0000135588.65188.14","article-title":"Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity","volume":"110","author":"Molloy","year":"2004","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets","volume":"8","author":"Libby","year":"2002","journal-title":"Nat Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/01.CIR.0000143174.41810.10","article-title":"Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques","volume":"110","author":"Fukumoto","year":"2004","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/CIRCULATIONAHA.105.562041","article-title":"Matrix metalloproteinase-13\/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques","volume":"112","author":"Deguchi","year":"2005","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/01.ATV.19.7.1640","article-title":"Increased secretion of basement membrane\u2013degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts","volume":"19","author":"Southgate","year":"1999","journal-title":"Arteriosc Thromb Vascul Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0008-6363(96)00211-8","article-title":"Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein","volume":"33","author":"George","year":"1997","journal-title":"Cardiovasc Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000235746","article-title":"Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound","volume":"28","author":"Yamada","year":"2009","journal-title":"Cerebrovasc Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/clc.4960231208","article-title":"Lipoprotein(a) is related to the extent of lesions in the coronary vasculature and to unstable coronary syndromes","volume":"23","author":"Zampoulakis","year":"2009","journal-title":"Clin Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-065X.2011.01046.x","article-title":"The inflammasome: an integrated view","volume":"243","author":"Gross","year":"2011","journal-title":"Immunol Rev."},{"key":"B22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","author":"Post","year":"1997","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","article-title":"High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study","volume":"108","author":"Kinlay","year":"2003","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/eurheartj\/eht260","article-title":"Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy","volume":"34","author":"Puri","year":"2013","journal-title":"Eur Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e005367","DOI":"10.1161\/JAHA.116.005367","article-title":"Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia","volume":"6","author":"Toth","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/ehv028","article-title":"Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial","volume":"36","author":"Cannon","year":"2015","journal-title":"Eur Heart J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/1744666X.2015.985658","article-title":"The evolution of our understanding of macrophages and translation of findings toward the clinic","volume":"11","author":"Martinez","year":"2015","journal-title":"Exp Rev Clin Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e45466","DOI":"10.1371\/journal.pone.0045466","article-title":"High-resolution transcriptome of human macrophages","volume":"7","author":"Beyer","year":"2012","journal-title":"PloS ONE"},{"key":"B35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCRESAHA.116.309194","article-title":"Abandoning M1\/M2 for a network model of macrophage function","volume":"119","author":"Nahrendorf","year":"2016","journal-title":"Circ Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12849","DOI":"10.1038\/ncomms12849","article-title":"PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation","volume":"7","author":"Iwata","year":"2016","journal-title":"Nat Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1253\/circj.CJ-13-0873","article-title":"The expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases","volume":"77","author":"Fukuda","year":"2013","journal-title":"Circ J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1161\/CIRCULATIONAHA.106.675462","article-title":"Delta-like 4 induces notch signaling in macrophages: implications for inflammation","volume":"115","author":"Fung","year":"2007","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"E1868","DOI":"10.1073\/pnas.1116889109","article-title":"Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders","volume":"109","author":"Fukuda","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1161\/ATVBAHA.115.305516","article-title":"Macrophage notch ligand delta-like 4 promotes vein graft lesion development: implications for the treatment of vein graft failure","volume":"35","author":"Koga","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.imbio.2017.02.003","article-title":"Crosstalk between glucocorticoids and IL-4 modulates Ym1 expression in alternatively activated myeloid cells","volume":"222","author":"Ng","year":"2017","journal-title":"Immunobiology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Ip","year":"2017","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1172\/JCI45444","article-title":"Kr\u00fcppel-like factor 4 regulates macrophage polarization","volume":"121","author":"Liao","year":"2011","journal-title":"J Clin Invest."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.4049\/jimmunol.1402797","article-title":"Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP","volume":"194","author":"Kapoor","year":"2015","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"169414","DOI":"10.1155\/2008\/169414","article-title":"Macrophages, PPARs, and Cancer","volume":"2008","author":"Van Ginderachter","year":"2008","journal-title":"PPAR Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metabol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fcvm.2018.00006","article-title":"Kruppel-like factors in vascular inflammation: mechanistic insights and therapeutic potential","volume":"5","author":"Sweet","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fimmu.2014.00420","article-title":"Metabolic reprograming in macrophage polarization","volume":"5","author":"Galvan-Pena","year":"2014","journal-title":"Front Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1083\/jcb.17.3.487","article-title":"Metabolic patterns in three types of phagocytizing cells","volume":"17","author":"Oren","year":"1963","journal-title":"J Cell Biol."},{"key":"B52","first-page":"97","article-title":"Some biochemical aspects of the immune macrophage","volume":"51","author":"Hard","year":"1970","journal-title":"Br J Exp Pathol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1042\/bj2390121","article-title":"Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages","volume":"239","author":"Newsholme","year":"1986","journal-title":"Biochem J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1001759","DOI":"10.1371\/journal.pbio.1001759","article-title":"Direct type I IFN but not MDA5\/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation","volume":"12","author":"Pantel","year":"2014","journal-title":"PLoS Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1042\/BJ20111386","article-title":"A critical role for citrate metabolism in LPS signalling","volume":"438","author":"O'Neill","year":"2011","journal-title":"Biochem J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i4.40\u00b7","article-title":"Cancer metabolism and the warburg effect as anabolic process outcomes of oncogene operation","volume":"20","author":"Ponizovskiy","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"19247","DOI":"10.1074\/jbc.M110.190298","article-title":"Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene","volume":"286","author":"Ruiz-Garcia","year":"2011","journal-title":"J Biol Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr Opin Cell Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.molmet.2016.04.005","article-title":"Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation","volume":"5","author":"Johnson","year":"2016","journal-title":"Mol Metab."},{"key":"B63","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia Response elements in the aldolase a, enolase 1, and lactate dehydrogenase a gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J Biol Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4049\/jimmunol.0901698","article-title":"Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation","volume":"185","author":"Rodriguez-Prados","year":"2010","journal-title":"J Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","article-title":"Mitochondrial dysfunction prevents repolarization of inflammatory macrophages","volume":"17","author":"Van","year":"2016","journal-title":"Cell Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cmet.2012.04.023","article-title":"The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism","volume":"15","author":"Haschemi","year":"2012","journal-title":"Cell Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"C1594","DOI":"10.1152\/ajpcell.1993.264.6.C1594","article-title":"Modulation of glucose metabolism in macrophages by products of nitric oxide synthase","volume":"264","author":"Albina","year":"1993","journal-title":"Am J Physiol Cell Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1194\/jlr.M600027-JLR200","article-title":"Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4","volume":"47","author":"Raetz","year":"2006","journal-title":"J Lipid Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.105.585703","article-title":"Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial","volume":"113","author":"Schoenhagen","year":"2006","journal-title":"Circulation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"39976","DOI":"10.1074\/jbc.M110.182915","article-title":"A mouse macrophage lipidome","volume":"285","author":"Dennis","year":"2010","journal-title":"J Biol Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/CIRCRESAHA.108.182428","article-title":"T-cell costimulation and coinhibition in atherosclerosis","volume":"103","author":"Gotsman","year":"2008","journal-title":"Circ Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tcm.2007.02.004","article-title":"CD40 and Its Ligand in Atherosclerosis","volume":"17","author":"Lutgens","year":"2007","journal-title":"Trends Cardiovasc Med."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.10.001","article-title":"Emerging targets in cancer immunotherapy","author":"Burugu","year":"2017","journal-title":"Semin Cancer Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s004280000239","article-title":"Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII)","volume":"437","author":"Hakkinen","year":"2000","journal-title":"Virchows Arch"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1161\/01.CIR.0000043029.52803.7B","article-title":"Oxidized low-density lipoprotein augments and 3-Hydroxy-3-Methylglutaryl coenzyme a reductase inhibitors limit CD40 and CD40L expression in human vascular cells","volume":"106","author":"Schonbeck","year":"2002","journal-title":"Circulation"},{"key":"B78","doi-asserted-by":"publisher","first-page":"11e","DOI":"10.1161\/01.ATV.0000050143.22910.62","article-title":"Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI","volume":"23","author":"Blake","year":"2002","journal-title":"Arteriosc Thromb Vascular Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1161\/01.CIR.0000127121.16815.F1","article-title":"B7-1\/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"109","author":"Buono","year":"2004","journal-title":"Circulation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1111\/bph.13802","article-title":"Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis","volume":"174","author":"Foks","year":"2017","journal-title":"Br J Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.yjmcc.2008.10.028","article-title":"Contributions of PD-1\/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis","volume":"46","author":"Lee","year":"2009","journal-title":"J Mol Cell Cardiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1093\/eurheartj\/ehx517","article-title":"CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice","volume":"38","author":"Winkels","year":"2017","journal-title":"Eur Heart J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1160\/TH16-04-0318","article-title":"CD70 limits atherosclerosis and promotes macrophage function","volume":"117","author":"Winkels","year":"2017","journal-title":"Thromb Haemost."},{"key":"B86","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm.4308","article-title":"VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer","volume":"23","author":"Gao","year":"2017","journal-title":"Nat Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e003031","DOI":"10.1161\/JAHA.115.003031","article-title":"NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis","volume":"5","author":"Paramel","year":"2016","journal-title":"J Am Heart Assoc."},{"key":"B89","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1365-2567.1998.00598.x","article-title":"Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c\/CD18-receptor mediated","volume":"95","author":"Netea","year":"1998","journal-title":"Immunology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0002-9149(01)01924-5","article-title":"Inflammatory pathways in atherosclerosis and acute coronary syndromes","volume":"88","author":"Plutzky","year":"2001","journal-title":"The Am J Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2018.01.046","article-title":"Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: results from the Multi-Ethnic Study of Atherosclerosis","volume":"259","author":"Simon","year":"2018","journal-title":"Int J Cardiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1253\/circj.CJ-15-1039","article-title":"Toll-like receptors and Src-family kinases in atherosclerosis \u2013 focus on macrophages","volume":"79","author":"Wang","year":"2015","journal-title":"Circ J."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/CIRCRESAHA.108.192880","article-title":"Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake","volume":"104","author":"Choi","year":"2009","journal-title":"Circ Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"B95","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.atherosclerosis.2014.04.020","article-title":"Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration","volume":"235","author":"Huang","year":"2014","journal-title":"Atherosclerosis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e002860","DOI":"10.1161\/JAHA.115.002860","article-title":"Systematic evaluation of the cellular innate immune response during the process of human atherosclerosis","volume":"5","author":"van","year":"2016","journal-title":"J Am Heart Assoc."},{"key":"B97","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.carpath.2010.06.002","article-title":"iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach","volume":"20","author":"Perrotta","year":"2011","journal-title":"Cardiovas Pathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.4049\/jimmunol.1000993","article-title":"ERK is integral to the IFN-gamma-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.105.543579","article-title":"CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study","volume":"112","author":"McDermott","year":"2005","journal-title":"Circulation"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.08.021","article-title":"CXCL4-induced macrophages in human atherosclerosis","author":"Domschke","year":"2017","journal-title":"Cytokine"},{"key":"B101","doi-asserted-by":"publisher","first-page":"E260","DOI":"10.3390\/ijms19010260","article-title":"Cytokine disturbances in coronary artery ectasia do not support atherosclerosis pathogenesis","volume":"19","author":"Boles","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1160\/TH14-06-0509","article-title":"Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function","volume":"113","author":"Han","year":"2015","journal-title":"Thromb Haemost."},{"key":"B103","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/cvr\/cvq211","article-title":"OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization","volume":"88","author":"Nakano","year":"2010","journal-title":"Cardiovasc Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev. Cardiology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"10.1146","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Ann Rev Physiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.tem.2011.03.005","article-title":"Human resistin: found in translation from mouse to man","volume":"22","author":"Schwartz","year":"2011","journal-title":"Trends Endocrinol Metabol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1371\/journal.pmed.0010045","article-title":"An inflammatory cascade leading to hyperresistinemia in humans","volume":"1","author":"Lehrke","year":"2004","journal-title":"PLoS Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2217\/fca-2016-0059","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease","volume":"13","author":"Han","year":"2017","journal-title":"Fut Cardiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1160\/TH09-01-0029","article-title":"The multi-functionality of CD40L and its receptor CD40 in atherosclerosis","volume":"102","author":"Lievens","year":"2009","journal-title":"Thromb Haemost."},{"key":"B110","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MCA.0b013e3282eff1ad","article-title":"Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro","volume":"18","author":"Dopheide","year":"2007","journal-title":"Coron Art Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3892\/br.2013.195","article-title":"Clinical implications of tenascin-C and OX40 ligand in patients with acute coronary syndrome","volume":"2","author":"Yang","year":"2014","journal-title":"Biomed Rep"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/CIRCULATIONAHA.109.882704","article-title":"CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice","volume":"121","author":"Jeon","year":"2010","journal-title":"Circulation"},{"key":"B113","first-page":"1525","article-title":"Elevated plasma levels and monocyte-associated expression of CD137 ligand in patients with acute atherothrombotic stroke","volume":"18","author":"Yu","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1399-0039.2002.600204.x","article-title":"Characterization of the murine CD30 ligand (CD153) gene: gene structure and expression","volume":"60","author":"Goldie-Cregan","year":"2002","journal-title":"Tissue Antig."},{"key":"B115","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO;2-H","article-title":"Association of coronary plaque rupture and atherosclerotic inflammation","volume":"181","author":"Boyle","year":"1997","journal-title":"J Pathol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e2115","DOI":"10.1038\/cddis.2016.33","article-title":"Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan","volume":"7","author":"Chen","year":"2016","journal-title":"Cell Death Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1172\/JCI31344","article-title":"Proatherogenic immune responses are regulated by the PD-1\/PD-L pathway in mice","volume":"117","author":"Gotsman","year":"2007","journal-title":"J Clin Invest."},{"key":"B118","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2016.10.019","article-title":"Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo","volume":"254","author":"Bekkering","year":"2016","journal-title":"Atherosclerosis"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/CIRCRESAHA.115.307599","article-title":"Disruption of glut1 in hematopoietic stem cells prevents myelopoiesis and enhanced glucose flux in atheromatous plaques of ApoE(-\/-) Mice","volume":"118","author":"Sarrazy","year":"2016","journal-title":"Circ Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2967\/jnumed.114.139428","article-title":"Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxia-inducible factor-1alpha activation through Nox2-dependent reactive oxygen species generation","volume":"55","author":"Lee","year":"2014","journal-title":"J Nuc Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"10459","DOI":"10.1074\/jbc.M110314200","article-title":"15-Deoxy-\u039412,14-prostaglandin J2 : a prostaglandin d2 metabolite generated during inflammatory processes","volume":"277","author":"Shibata","year":"2002","journal-title":"J Biol Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.fjc.0000194252.38683.68","article-title":"Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization","volume":"47","author":"Gomez-Hernandez","year":"2006","journal-title":"J Cardiovasc Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1096\/fj.14-265363","article-title":"Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice","volume":"29","author":"Akagi","year":"2015","journal-title":"FASEB J"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032801","article-title":"ERV1\/ChemR23 signaling protects from atherosclerosis by modifying oxLDL Uptake and Phagocytosis in Macrophages","author":"Laguna-Fernandez","year":"2018","journal-title":"Circulation"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e102362","DOI":"10.1371\/journal.pone.0102362","article-title":"Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages","volume":"9","author":"Deng","year":"2014","journal-title":"PloS One"},{"key":"B126","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1034\/j.1600-0773.86.s1.7.x","article-title":"New safe medicines faster: a proposal for a key action within the european union's 6th framework programme","volume":"86","author":"Bjerrum Ole","year":"2003","journal-title":"Pharmacol Toxicol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1741-7007-8-61","article-title":"When failure should be the option","volume":"8","author":"Petsko","year":"2010","journal-title":"BMC Biol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4161\/mabs.3.5.16968","article-title":"Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates","volume":"3","author":"Munro","year":"2011","journal-title":"mAbs"},{"key":"B129","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ejps.2012.09.020","article-title":"Towards a European strategy for medicines research (2014-2020): the EUFEPS position paper on Horizon 2020","volume":"47","author":"Gaspar","year":"2012","journal-title":"Eur J Pharmaceut Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12967-016-0838-4","article-title":"Changing R&D models in research-based pharmaceutical companies","volume":"14","author":"Schuhmacher","year":"2016","journal-title":"J Trans Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejps.2011.07.006","article-title":"Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe","volume":"44","author":"Bjerrum","year":"2011","journal-title":"Eur J Pharmaceut Sci."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T15:00:41Z","timestamp":1533308441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":131,"alternative-id":["10.3389\/fcvm.2018.00097"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2018.00097","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"article-number":"97"}}